Supplementary Information Tables:  2016-17 Departmental Results Report

• Previous Page
• Table of Contents
• Next Page

Horizontal Initiatives

• Chemicals Management Plan
• Federal Tobacco Control Strategy
• Jordan's Principle - A Child-First Initiative

Chemicals Management Plan

General Information

Lead departments

Health Canada

Environment and Climate Change Canada

Federal partner organizations

Health Canada

Healthy Environments and Consumer Safety Branch:

• Safe Environments Directorate;
• Consumer Product Safety Directorate; and,
• Environmental and Radiation Health Sciences Directorate.

Health Products and Food Branch:

• Biologics and Genetic Therapies Directorate;
• Food Directorate;
• Policy, Planning and International Affairs Directorate; and
• Veterinary Drugs Directorate.

Pest Management Regulatory Agency
Regulatory Operations and Regions Branch:

• Consumer Product Safety Program; and,
• Environmental Health Program.

Public Health Agency of Canada

• Health Security Infrastructure Branch:
• Centre for Emergency Preparedness and Response.

Environment and Climate Change Canada
Environmental Protection Branch:

• Industrial Sectors, Chemicals and Waste Directorate;
• Legislative and Regulatory Affairs Directorate;
• Energy and Transportation Directorate; and,
• Environmental Protection Operations Directorate.

Science and Technology Branch:

• Science and Risk Assessment Directorate;
• Wildlife and Landscape Sciences Directorate;
• Atmospheric Science and Technology Directorate; and,
• Water Science and Technology Directorate.

Enforcement Branch:

• Environmental Enforcement Directorate.

Strategic Policy Branch:

• Economic Analysis Directorate.

Non-federal and non-governmental partner

Not applicable

Start date of the horizontal initiative

2016-17 (third phase)

2011-12 (second phase)

2007-08 (first phase)

End date of the horizontal initiative

2020-21

Total federal funding allocated (from 2007-08 to 2020-21) (dollars)

$1,308,179,400 (includes all three phases)

Total federal planned spending to March 31, 2017 (dollars) (includes the first and second phases of CMP)

$814,892,950 (phases one and two)

$98,657,290 (Phase three, year one, 2016-17)

Total federal actual spending to March 31, 2017 (dollars) (includes the first and second phases of CMP)

$776,085,148 (phases one and two)

$95,537,008 (Phase three, year one, 2016-17)

Funding contributed by non-federal and non-governmental partners (dollars)

Not applicable

Governance structures

In the overall delivery of the CMP, Health Canada and Environment and Climate Change Canada have a shared responsibility in attaining objectives and results. In meeting their obligations pursuant to the CMP, the Departments deliver their responsibilities through established internal departmental governance structures, as well as a joint CMP governance structure to address shared responsibilities. Efforts are also made to harmonize vertical and horizontal performance reporting indicators (e.g. Program Activity Architecture (PAA), CMP Performance Management Strategy, the CMP contribution to the Federal Sustainable Development Strategy, etc.) for CMP.

The CMP has a horizontal governance framework which ensures integration, co-ordination, joint decision making and clear accountabilities. Under the CMP Integrated Horizontal Governance Framework, the joint CMP Assistant Deputy Ministers Committee (CMP ADM Committee) reports to both the Health Canada and Environment and Climate Change Canada Deputy Ministers.

The CMP ADM committee is supported by a DG committee. The CMP DGs Committee consists of Directors General from all partner programs within Health Canada and Environment and Climate Change Canada, and provides strategic direction, oversight and a challenge function for the CMP's overall implementation. The CMP DGs also play a lead role in directing, monitoring and providing a challenge function for the core elements of the CMP, namely the delivery of the chemicals agenda under the Canadian Environmental Protection Act (CEPA).

This Director General level committee is supported by the CMP Steering Committee, which is a Director level committee intended to provide oversight on CMP issues related to the CEPA chemicals agenda.

Contact information

Suzanne Leppinen
Director, Chemicals and Environmental Health Management Bureau
Safe Environments Directorate
Healthy Environments and Consumer Safety Branch
Health Canada
269 Laurier Avenue West
Ottawa, Ontario, K1A 0K9
Postal Locator: 4905B
Telephone: 613-941-8071
E-mail: Suzanne.leppinen@hc-sc.gc.ca

Julie Thompson
Executive Director, Program Development and Engagement
Program Development and Engagement
Science and Risk Assessment Directorate
Environment and Climate Change Canada
351, boul. Saint-Joseph, 6^th Floor
Gatineau, QC, K1A 0H3
Telephone: 819-938-5144
E-mail: julie.thompson3@canada.ca

Results Information

Description of the horizontal initiative

Originally launched in 2006, the Chemicals Management Plan (CMP) enables the Government of Canada to protect human health and the environment by addressing substances of concern in Canada. It is a science-based approach that includes:

• setting priorities and government-imposed timelines for risk assessment and risk management of chemicals and other substances of concern;
• enhancing research, monitoring and surveillance;
• increasing industry stewardship and responsibilities for substances;
• collaborating internationally on chemicals assessment and management;
• communicating to Canadians the potential risks of chemical and other substances; and,
• engaging industry to inform risk assessment and risk management action while also enhancing trust in the program.

Jointly managed by Health Canada (HC) and Environment and Climate Change Canada (ECCC), the CMP brings all existing federal chemical programs together under a single strategy. This integrated approach allows the Government of Canada to address various routes of exposure to chronic and acute hazardous substances. It also enables use of the most appropriate management tools among a full suite of federal laws, which include the Canadian Environmental Protection Act, 1999 (CEPA), the Canada Consumer Product Safety Act (CCPSA), the Food and Drugs Act (F&DA), the Pest Control Products Act (PCPA), the Fisheries Act and the Forestry Act.

In the second phase of CMP (CMP2), priority setting for existing substances was refined and the remaining substances were grouped to provide efficiencies for risk assessment and risk management as a result of lessons learned from the first phase of the program (CMP1). The third phase (CMP3) includes both substance groupings and single substance assessments. Similar to CMP2, groupings are created where possible to gain efficiencies in the assessment process. Where groupings are not possible, single substance assessments are conducted.

Integration across government programs remains critical since many remaining substances are found in consumer, cosmetic, health, drug and other products. In addition to releases from products, substances may be released at various points along other areas of their life cycle, such as during the manufacturing and disposal.

The same core functions that have been part of phases one and two continue in phase three of the CMP: risk assessment; risk management, compliance promotion and enforcement; research; monitoring and surveillance; stakeholder engagement and risk communications; and, policy and program management. Information gathering is a key activity undertaken to support these core functions.

For more information, see the Government of Canada's Chemical Substances Portal .

Fiscal year of planned completion of next evaluation

2018-19, led by the Office of Audit and Evaluation, HC/PHAC

Shared outcomes of Federal Partners

Immediate Outcomes:

• Research knowledge on substances of concern is made available to Health Canada and Environment and Climate Change Canada recipients to inform risk assessment, risk management, risk communication and stakeholder engagement, monitoring and surveillance, and international activities;
• Information on the risks of substances is used by Health Canada and Environment and Climate Change Canada recipients to inform risk management, risk communication and stakeholder engagement, monitoring and surveillance, and research activities;
• Data on the use, release, exposure and presence of substances of concern in humans, the environment, food and consumer products is used by Health Canada and Environment and Climate Change Canada recipients or other stakeholders;
• Targeted industry conforms or complies with requirements of risk management measures; and
• Targeted industry takes voluntary or enforced action to protect Canadians and the environment.

Intermediate Outcomes:

• Risks associated with harmful substances in humans, the environment, food, pesticides, and consumer products are prevented, minimized or eliminated;
• Targeted industry understands its obligations to take action to protect Canadians and the environment;
• Canadians use information to avoid or minimize risks posed by these substances;
• Canadians and stakeholder groups understand information on the risks and safe use of substances of concern; and,
• Improved program decision-making and program performance.

Final Outcome:

• Reduced threats to health and the environment from harmful substances.

Performance indicator(s):

Performance indicators are under development, as part of a program review of the Performance Measurement Framework for the third phase of the Chemicals Management Plan. These performance indicators and targets will be reported in the 2017-18 Departmental Results Report.

Target(s):

Targets are under development, as part of a program review of the Performance Measurement Framework for the third phase of the Chemicals Management Plan. These performance indicators and targets will be reported in the 2017-18 Departmental Results Report.

Data source(s) and frequency of monitoring and reporting:

Performance indicator data sources are under development, as part of a program review of the Performance Measurement Framework for the third phase of the Chemicals Management Plan. These performance indicators and targets will be reported in the 2017-18 Departmental Results Report.

Results:

Performance indicators are under development, as part of a program review of the Performance Measurement Framework for the third phase of the Chemicals Management Plan. These performance indicators and targets will be reported in the 2017-18 Departmental Results Report.

Performance information

2016-17 Performance Highlights:

In 2016-2017, HC and ECCC continued to assess and manage the potential health and ecological risks from remaining priority existing substances. Screening Assessment Reports and Risk Management Strategies for most priorities identified in a publicly available work plan were completed, and risk management measures continued to be developed, implemented, tracked and monitored. As well, new substance notifications were assessed within their mandated timelines, and risk management instruments for these new timelines were developed, within mandated timeframes, as required for substances considered harmful to human health and/or the environment.

HC continued to conduct risk assessments and develop and implement risk management measures to address risks posed by harmful substances in foods and food packaging materials, consumer products, cosmetics and drinking water while work continued on the re-evaluation of previously approved pesticides according to legislated timelines and requirements under the Pest Control Products Act.

The program continued to conduct research and monitoring programs to address existing and emerging substances of concern, and to inform risk assessment and risk management activities.

Compliance strategies and enforcement plans were also developed and delivered for CMP substances. The focus in 2016-17 was on delivering compliance promotion and enforcement activities for the highest priority instruments as determined by the compliance and enforcement priority setting processes. Regions conducted activities to support compliance promotion for stakeholders regarding their legal obligations related to CMP (e.g., reporting requirements reminders, information sessions, stakeholder database updates). Enforcement also undertook region specific activities in order to ensure compliance with the regulatory instruments.

Stakeholder engagement and public outreach activities continued in 2016-17. The first term of the CMP Science Committee ended in the fall of 2016, and the open call for the second term of the Committee was posted on the chemical substances website to solicit nominations for a new core membership. The CMP Stakeholder Advisory Council was renewed for the third phase of the CMP where a communications sub-group was created in May 2016 to seek input from stakeholders to improve CMP communications products. Capacity building contracts with certain Non-Government Organisations (NGOs) have been implemented by Health Canada to serve as a single window for incoming/outgoing information about the CMP to other NGOs and indigenous groups. Public Outreach continues to be delivered via multiple platforms, such as a national media campaign, and grass roots outreach by HC regional partners among others. A Social Marketing Strategy was developed to foster behaviour change to protect children's health, and a Public Opinion Research Project was implemented that explored behavioural and information seeking trends of Canadians related to chemicals and environmental health.

ER 1.1 Expected Results/ PI 1.1 Performance Indicators/ T 1.1 Targets:

Health Canada

• Information on risks of substances to inform risk management, monitoring and surveillance and research activities (Risk Assessment);
• Risk management measures under CEPA, PCPA, CCPSA and F&DA (Risk Management, Compliance Promotion and Enforcement);
• New/updated drinking water quality guidelines/guidance documents (Risk Management, Compliance Promotion and Enforcement);
• Science-based information on the risks posed by substances, in accordance with annual research plans (Research);
• Data generated on the use, release, exposure and presence of substances of concern in humans, the environment, food and consumer products (Monitoring and Surveillance); and,
• Engagement, consultation and communication products to inform the public and stakeholders (Stakeholder Engagement and Risk Communications).

ER 2.1 Expected Results/ PI 2.1 Performance Indicators/ T 2.1 Targets:

Public Health Agency of Canada

• Mitigation of human health risks associated with contamination of water, food and sanitation on board passenger conveyances (Risk Management, Compliance Promotion and Enforcement).

ER 3.1 Expected Results/ PI 3.1 Performance Indicators/ T 3.1 Targets:

Environment and Climate Change Canada

• Information on risks of substances to inform risk management, monitoring and surveillance and research activities (Risk Assessment);
• Risk management measures under CEPA and/or Fisheries Act;
• Science-based information on the risks posed by substances, in accordance with annual research plans (Research);
• Data generated on the use, release, exposure and presence of substances of concern in humans, the environment, food, consumer products and waste (Monitoring and Surveillance);
• Information on obligations to conform or comply with risk management control measures (Compliance Promotion); and,
• Inspections, investigations and enforcement actions

AR 1.1/AR 3.1 Actual Results:

Health Canada and Environment and Climate Change Canada

Risk Assessment/Risk Management

A key component of the CMP has been the assessment, and management as appropriate, of the potential risks of 4,363 priority substances already on the Canadian market (existing substances) by 2021. The third phase of the CMP, which began in 2016-17 and will be in place until 2020-2021, is intended to assess the approximately 1,550 of the 4363 remaining priority substances. In 2016-17, 358 CMP substances were assessed in Draft Screening Assessment Reports (DSARs). The following lists the substances, or groups of substances, for which DSARs were completed in 2016-17.

Substances or group of substances

• coal tars
• asphalt
• distillate aromatic extracts
• boron-containing substances
• certain organic flame retardants
• substituted diphenylamines
• 2-ethylhexanoic acid
• 2-ethyl derivatives
• formic acid and formats
• chloral hydrate
• alkyl sulfates and olefin sulfonate
• short-chain alkanes
• acetic acid anhydride
• 4-vinylcyclohexene
• 2-methyl benzene sulfonamide
• sulfurized lard oil
• RS polymer II
• ethylene glycol ethers
• 1-methyl-2-Pyrrolidinone/1-ethyl-2-pyrrolidinone
• 1-ethyl-

As of March 31, 2017, ECCC and HC published final screening assessment reports (FSARs) for 2,653 substances (61% of the 4,363). In 2016-17, 1,162 CMP substances were assessed in FSARs. In addition, four Science Approach documents were published covering 749 low concern CMP3 substances. Assessment conclusions for these substances will be included in screening assessment reports at a later date. The following lists the substances, or group of substances, for which FSARs were published in 2016-17.

Substances or group of substances

• BDTP
• Ethane
• Ethylbenzene
• HCE
• heavy fuel oils
• petrolatum and waxes
• triclosan
• natural gas condensates
• liquefied petroleum gases
• aromatic azo and benzidine-based substances
• internationally classified substances
• RS III
• RS polymers
• RS pesticides

In 2016-17, ECCC and HC also jointly performed the screening assessment of micro-organisms listed on the Domestic Substances List (DSL). Draft Screening Assessments for eight microorganisms were published in the Canada Gazette, Part I for a 60-day public comment period. Final Screening Assessments Report for eight micro-organisms was also published in the Canada Gazette, Part I. As of March 31, 2017, HC and ECCC published final screening assessment reports for 38 micro-organisms (55% of the 69). Work continues on the remaining screening assessments for several other micro-organisms of high and medium priority that are on the DSL.

Risk management measures continued to be developed, implemented, tracked and monitored. Work with other jurisdictions bilaterally and in multinational fora to undertake regional and multilateral efforts to manage chemicals of concern also continued. Targeted risk management activities were published in 2016-17 for substances that were deemed harmful to human health and/or the environment. In total, there were 18 risk management instruments put in place to manage these toxic substances. Risk management instruments were developed under CEPA (1999) or another Act.

Proposed risk management instruments in 2016-17 include: Environmental Emergency Regulations, 2016; Microbeads in Toiletries Regulations, Regulations Amending the Prohibition of Certain Toxic Substances Regulations, 2012 [BNST]; Proposed Regulations Amending the Export of Substances on the Export Control List Regulations [Mercury]); Significant New Activity (SNAc) NOI as part of the CP/SP SNAc Review [19 substances]; Federal Environmental Quality Guidelines for PFOS, Triclosan, Chromium and Bisphenol A.

Final risk management (RM) instruments include: Federal Environmental Quality Guidelines for chlorinated alkanes, HBCD, Vanadium; Regulations Repealing the Vinyl Chloride Release Regulations, 1992; Regulations Amending the Prohibition of Certain Toxic Substances Regulations, 2012 [PBDEs, PFOS, LCPFCAs, HBCD, PFOA]; Code of Practice for DEGME; Code of Practice for the Environmentally Sound Management of End-of-life Lamps Containing Mercury; two food additives delisted from F&DA List of Permitted Food Additives. A Federal Environmental Quality Guidelines was finalized for TBBPA.

Six RM Scope documents (boric acid, its salts and its precursors; coal tars and their distillates; DBDPE, DP and TCPP from Certain Organic Flame Retardants substance grouping; 2-ethylhexyl-2-ethylhexanoate) and, five RM Approach documents (ethyl carbamate, triclosan, natural gas condensates, liquefied petroleum gases, azos disperse yellow 3) were published.

Five SNAN risk assessment summaries were issued for three toxic substances (hydroquinone, epichlorophyrin [2], benzyl chloride) and one non-toxic substance (phenol, methylstyrenated). SNAN risk assessment summaries provide information on the notified activity, the substance that was notified, the environment and human health risk assessment conclusions, and risk management considerations.

In total, six SNAc Notices of Intent (NOIs) were issued for 109 substances, 19 of which are toxic. Notices were issued proposing to apply the SNAc provisions to 76 substances, five notices were issued proposing to vary the requirement for 31 substances, including 19 toxic substances, and two notices were published proposing to rescind the application of the SNAc provisions to two substances. Four final orders were issued for 26 substances, eight of which are toxic. Three orders were published rescinding the application of the SNAc provisions for 25 substances, eight of which are toxics. One order was issued applying the SNAc provision to one organism.

All 473 new substance notifications accepted from industry and due in 2016-17 were assessed, including those for living organisms. Of the 473 substances, 372 were chemicals and polymers, 68 were products of biotechnology, 4 were nanomaterials, and 29 were chemicals, polymers and living organisms in products regulated as Food and Drugs Act. Seven SNAc Notices and three Ministerial Conditions were issued in 2016-17, with no prohibitions.

HC has completed prioritization of the Revised "In Commerce List" (ICL) of substances in products regulated under the F&DA that were in Canadian commerce between January 1, 1987 and September 13, 2001, as well as processing new nominations to this list. All nominations received to the revised In Commerce List (ICL) (22 in total) were processed and all the substances that were found to be eligible for addition to the revised ICL were added during 2016-17. All substances on the revised ICL were prioritized by fall of 2016, meeting the CMP2 commitment, and stakeholders received a draft of Revised ICL prioritization decisions in September 2016. Assessment of these prioritized substances has begun with a target 20 substances planned to be assessed in 2017-18.

A total of three mandatory information gathering initiatives were issued under section 71 of CEPA for: HFCs (20 substances), Asbestos (seven substances) and chemicals and polymers as part of the 2017 Inventory Update (1430 substances). In addition, a total of four voluntary data gathering initiatives on 45 organic groupings and 14 inorganic groupings were conducted in the summer and fall of 2016 to inform CMP3 assessments.

Maintaining up-to-date knowledge of commercial activities of chemical substances in Canada continues to be important for the delivery of the Government's domestic and international commitments. While information received during the first and second phases of the Inventory Update (IU) was critical to inform priority setting under the CMP, the 2017 IU was designed to support decision making for work beyond the CMP. Emerging science, evolving domestic and international programs and chemical market fluctuations will continue to be considered in order to ensure future priorities are reflective of Canada's dynamic market.

Health Canada also contributed to risk management activities related to drinking water quality in 2016-17. These activities are described elsewhere under Section II, Sub-Program 2.3.2: Water Quality in the 2016-17 DRR, as well as under Goal 3, Target 3.2: Drinking Water Quality, in the 2016-17 Sustainable Development Supplementary Information Table.

Highlights for work related to consumer products and cosmetics in 2016-2017 included: completing method development and testing of CMP substances, such as the determination of MCI-MI in cosmetic products; a cyclical enforcement project where inspections in cosmetics were carried out at 36 establishments, on 82 products and one voluntary recall and five stop sales were conducted; the development and validation of a test method for fragrances in cosmetic products; and, a preliminary study of dermal adsorption of chloro-phosphate flame retardants from polyurethane products to support risk assessment activities and risk management actions. Consumer Product Safety risk assessors and risk managers reviewed assessment documents from Petroleum Streams 1-4, legacy substances and Challenge substances. Risk assessors also completed product risk assessments, such as completing the risk assessment for phenacetin and diethyl phthalate, the latter of which will feed into the second phase of CMP Phthalate grouping, and the review of Cosmetic Hotlist ingredients, which includes enforcement projects on the use of boric acid in cosmetic products. Risk assessors and support staff provided cosmetic notification data to support the assessment of numerous Challenge substances. Risk managers were also involved with review of proposed risk management measures for microbeads, ethylbenzene, boric acid, MDI/MDA, pigment red 4, and triclosan.

The Health Products and Food Branch (HPFB) of Health Canada continued to provide information to support the development of CMP screening assessments as well as provide a review function for food-related sections of those assessments. It also continued its commitment to re-evaluate and assess food additives, food contaminants, other food ingredients and food packaging materials for which CMP screening assessments and new science identified potential risks for consumers and where CMP assessments identified food as a contributing/main source of exposure.

HPFB reviewed and evaluated 178 requests/reports to determine whether a chemical substance or excipients used in biologics drugs that are sold in Canada are on the approved DSL. Work also continued to finalize the regulatory framework for environmental assessment of active pharmaceutical ingredients in drugs regulated under the FDA. Internal consultations are underway with external consultations expected to occur in late 2017. Health Canada made amendments to the Food and Drugs Regulations to create a more efficient and responsive framework for risk management of contaminants and other adulterating substances in food, as well as delisting two substances from the Department's Lists of Permitted Food Additives (Epichlorohydrin and 2-Nitropropane) that were concluded to be harmful to human health under CMP. Continued research is being conducted on how non-regulatory initiatives can be used as a risk management tool to reduce exposure to the environment of substances/products regulated under the FDA.

In 2016-17, Health Canada also completed the re-evaluation of 15 active ingredients and the special review of eight active ingredients used in previously approved pesticides. This result includes an additional 9 re-evaluations and 4 special reviews that were completed in 2016-17 despite being on the forward schedule of the five year work plan. As well, Health Canada completed the proposed decisions for the re-evaluation of 17 active ingredients and the proposed decisions for the special review of 8 active ingredients used in previously approved pesticides.

Stakeholder Engagement and Public Outreach

The first two meetings of the CMP Stakeholder Advisory Council (SAC) under the renewed five-year mandate took place on April 28, 2016 and on November 23, 2016. The purpose of the Council is to obtain stakeholders' advice on the implementation of the CMP and to foster dialogue on related issues between stakeholders and government. The SAC has created a communications sub-group to look at communication issues related to the CMP. The sub-group met regularly and analyzed the current state of awareness of the CMP. It also looked at the communication mechanisms used with different stakeholder groups, as well as potential information gaps. The sub-group has identified potential opportunities and strategies to address and improve CMP communication with different stakeholder groups. Recommendations and examples of communication products were discussed at the Council's November 2016 meeting. For additional information, visit the Stakeholder Advisory Council webpage .

In November 2016, the government hosted multi-stakeholder workshops to engage and receive input from stakeholders on issues important to chemicals management in Canada. Topics discussed included: CMP high level updates on research and monitoring, information gathering for CMP3 substances, including substances regulated under the Food and Drug Act (ICL), risk assessment and risk management, and international activities.

Two issues of the CMP Progress Report were published in July 2016 and January 2017. The CMP Progress Report has been created to keep stakeholders and other interested parties up to date on the activities and programs related to the CMP. The report is produced jointly by ECCC and HC and is published twice a year. It reports on advances in major initiatives and highlights key activities related to the Government of Canada's recent work under the CMP. It also provides information about up-coming events, dates of interest and how to get involved.

The CMP Science Committee held its fifth meeting this fiscal year. On November 16-17, 2016, considerations for integrating new approach methodologies within the CMP were presented. Members engaged in constructive discussions as they continued developing the Committee's scientific input for the Government of Canada. The first term of the Committee ended in the fall of 2016, and the open call for the second term of the Committee was posted on the chemical substances website to solicit nominations for a new core membership. Input from the Science Committee ensures a strong science foundation to the CMP by providing external, scientific expertise to HC and ECCC on scientific issues.

Stakeholder awareness activities were undertaken in 2016-17, focusing on targeted stakeholders, in order to facilitate information sharing. These activities included the continuation of the HC webinar series with non-industry health and environment stakeholders. Sessions included risk management, public outreach, and enforcement under the CMP. The regions delivered 123 stakeholder engagement activities related to chemical effects on health and approximately 23, 256 brochures were distributed. The number of interactions with stakeholders was approximately 10,775 throughout the country.

The renewal of regional stakeholder inventories was also undertaken to enhance information gathering, compliance promotion and industry outreach.

In 2016-17, a number of public outreach activities were conducted nationally and in the HC Regional Offices to increase public awareness of the CMP, its achievements and broader environmental health issues. Highlights included the publication of plain language summaries and social media posts for high profile CMP substances, such as boric acid, coal tars, organic flame retardants, triclosan and phthalates. A series of articles were distributed to media outlets across Canada on household chemicals, including asbestos. Development has begun on a new marketing campaign and a national public opinion research study was completed in 2017 to inform the campaign's design. A CMP information article was developed that targeted science journalists to inform their reporting on the program. Environmental health guides for seniors were distributed across Canada to increase awareness of health risks in the home, as well. Outreach on senior's environmental health included a national blog post and distribution of health guides at trade shows, reaching over 30,000 people.

As part of the program's robust grassroots outreach program, the regions delivered 123 engagement activities related to chemical effects on health, and approximately 20,256 brochures were distributed. The number of interactions with the public and stakeholders was approximately 10,775 throughout the country. Regional staff delivered 49 chemical awareness learning (CAL) sessions to over 950 participants to help increase awareness of the CMP and provide advice to frontline service providers - including First Nations and early childhood educators - on ways to mitigate chemical-related health risks.

Research

Research continued to address priorities identified under the following themes: a) Effects, b) Exposure, and, c) Methods and Tools Development, in order to better understand the exposure and effects of chemicals and to contribute to the development of better methods for chemical hazard and exposure assessment. Research was ongoing on the exposure and toxicity of CMP priority chemicals such as potential reproductive and endocrine disrupting compounds, metals, flame retardants and nanomaterials.

In 2016-17 Health Canada continued to fund 19 research projects on a number of subjects, such as; the distribution of chemical substances in the dust of Canadian houses and residential microenvironments, the effects of flame retardants and other chemicals on endocrine and reproductive systems and on adipogenesis (fat cell formation), as well as their potential developmental neurotoxicity. In addition, focused research took place in order to develop quantitative approaches for improved regulatory evaluation and risk assessment of genotoxic substances, as well as case studies on the application of integrated testing strategies in human health risk assessment.

In addition, six targeted research/monitoring and surveillance projects were funded to generate data to help meet 2020 CMP risk assessment commitments. The ongoing projects include: the development of genetic toxicity testing strategies for prioritized data-poor CMP chemicals; a toxicokinetics study of four rare earth metals to develop methods to interpret biomonitoring measures; a study to develop biomonitoring equivalents for organics and inorganics; a study to analyze exposure to selected flame retardants and chlorinated paraffins using the Canadian House Dust Study samples; and, an in vitro pharmacokinetics study for high throughput data interpretation. Furthermore, a new study was funded to generate biomonitoring data and Canadian reference ranges for specific metals/trace elements for use in risk assessments under CMP3, and to examine the relationship between exposure and specific health outcomes in Canadians.

HC scientists published approximately 80 research papers related to the CMP in 2016-17.

ECCC initiated 17 new research projects on environmental exposure and toxicity of priority chemicals such as, flame retardants, benzotriazoles and benzothiazoles, platinum group elements, and rare earth elements. ECCC also continued five nanomaterials research projects to address chemical-physical properties characterization and toxicity data gaps for manufactured nanomaterials. ECCC scientists published approximately 70 research papers related to these projects in 2016-17.

Monitoring and Surveillance

HC and ECCC continued to conduct monitoring programs to address existing and emerging chemicals of concern, and to inform risk assessment needs and risk management activities. At ECCC, a total of 320 substances and/or groups of substances were measured in select media; fresh water, sediments, fish, ambient air, birds and municipal wastewater.

In 2016-17 Health Canada funded four monitoring and surveillance studies focusing on human exposure to contaminants, including biomonitoring of selected novel flame retardants and synthetic musks, measurements of various VOCs metabolites in urine, and measurements of halogenated flame retardants in blood of children recruited from a large birth cohort study.

HC's human biomonitoring efforts continued in 2016-17 with the Canadian Health Measures Survey (CHMS) and the Maternal-Infant Research on Environmental Chemicals (MIREC) study:

As part of the CHMS, laboratory analyses for cycle 4 (2014-15) were completed and data analysis was underway in relation to the Fourth Report on Human Biomonitoring of Environmental Chemicals in Canada, to be published in 2017-18. In addition, sample collection for cycle 5 (2016-17) continued. New priority chemicals for inclusion in cycle 7 (2020-2021) and beyond were identified through stakeholder outreach and laboratory consultations.

The MIREC study continued to monitor mothers and infants by measuring their exposure to environmental chemicals. In 2016-17,six MIREC journal articles were published including biomonitoring results for organophosphate (OP) pesticides, perfluoroalkyl substances (PFASs) and other persistent organic pollutants (POPs), metals (lead, cadmium, arsenic, mercury and manganese) and chemical mixtures. Extension of the MIREC Research Platform has been approved to measure additional chemicals such as glyphosate, additional phthalates, bisphenol A substitutes, OP flame retardants and the organic solvents NMP and NEP in biobanked maternal samples.

In 2016-17, Health Canada funded six human biomonitoring and health projects under the Northern Contaminants Program (NCP). These one year projects addressed interactions between contaminants and affected health outcomes, links between contaminant exposure and health, implementation of health communication tools, modelling of human exposure to contaminants, and collection of biomonitoring data among key population groups including mothers in Nunavik, Quebec and adults from indigenous communities in the NWT. The human health report for the fourth Canadian Arctic Contaminants Assessment Report (CACAR IV) has been completed and will be released in 2017-18.

Compliance and Enforcement

Compliance promotion relates to the planned activities that are undertaken to increase awareness, understanding and compliance with the law and its regulations. Through these activities, compliance promotion officers provide information to regulated communities on what is required to comply with the law, the benefits of compliance and the consequences of non-compliance. The goal is to achieve desired environmental results more efficiently through education and awareness-building, which helps mitigate consequential enforcement actions.

Each year, ECCC develops an annual list of priorities for delivery of compliance promotion activities on issues such as chemical management, air pollutants, and greenhouse gas emissions. Factors that influence the identification of priority activities include the recent publication of new or amended regulatory and non-regulatory instruments, new requirements coming into force, level of compliance, and need to maintain awareness, understanding, or compliance for specific requirements. The Department continues to focus compliance promotion efforts on regulatory and non-regulatory instruments that target geographically dispersed, hard-to-reach, small and medium-sized enterprises, Indigenous peoples, and federal departments. Resources are aligned with these identified compliance promotion priorities.

In 2016-17 compliance promotion activities were carried out for the following regulatory and non-regulatory instruments related to CMP substance:

• Storage Tank Systems for Petroleum Products and Allied Petroleum Products Regulations
• Export and Import of Hazardous Waste and Hazardous Recyclable Material Regulations;
• PCB Regulations;
• Products Containing Mercury Regulations;
• Prohibition of Certain Toxic Substances Regulations;
• Tetrachloroethylene (PERC) Regulations (Use in Dry Cleaning and Reporting Requirements); and
• Code of Practice for the Environmental Management of Road Salts

The compliance promotion activities reached approximately 13,000 companies and facilities subject to those instruments. Multiple approaches were used to reach the regulated communities, including workshops, information sessions, presentations, information package emails/mail-outs, articles, phone calls, and social media platforms. Many of these activities were carried out in collaboration with provincial and territorial governments, as well as non-governmental organizations and associations. For instance, the Quebec region developed a strong working relationship with the Association pour le Développement et l'Innovation en Chimie au Québec which provides an opportunity for each party to focus efforts on areas of strength and expertise. An article regarding the Prohibitions Regulations was published in the November 2016 issue of The Canadian Journal of Chemical Engineering as a first step in the development and implementation of guidance for the regulated community. These, and many other successful activities, have helped to increase the awareness and contribute to the understanding of and compliance with ECCC's regulatory and non-regulatory instruments related to CMP substances.

In 2016-17, ECCC conducted enforcement activities under CMP regulations. Highlights included the activities below under the Storage Tank Systems for Petroleum Products and Allied Petroleum Products Regulations (STSR), the Environmental Emergency Regulations, and the Chromium Electroplating, Chromium Anodizing and Reverse Etching Regulations: Storage Tank Systems for Petroleum Products and Allied Petroleum Products Regulations (STSR)

ECCC began a new project to increase compliance with the registration requirements of section 28 of the Storage Tank Systems for Petroleum Products and Allied Petroleum Products Regulations (STSR) on Aboriginal and federal lands. A considerable proportion of infractions under CEPA are under the STSR; section 28 is the second most common area of non-compliance found under the STSR in the past five years.

The project is intended to increase compliance with the identification of storage tank systems that are not currently registered in the Federal Identification Registry of Storage Tanks Systems database (FIRSTS). Systems that are not identified are likely non-compliant with other requirements of the STSR; without knowing who they are it is not possible to undertake compliance promotion activities.

Compliance with the STSR is important to reduce the risk of soil and groundwater contamination as a result of spills and leaks of petroleum products from storage tank systems located on federal and Aboriginal lands. Leaks from storage tank systems can have serious environmental impacts. Small quantities of diesel and gasoline can contaminate surface and subsurface soils, render drinking water from aquifers non-potable, and create explosive build-ups of vapours in basements and other underground structures.

The project began in July 2016. By the end of fiscal year 2016-17, 126 new storage tank systems had been registered in FIRSTS as a result of the project.

Environmental Emergency Regulations

In 2016-17, a project was conducted under the Environmental Emergency Regulations (E2 Regulations). The objectives of the E2 Regulations are to reduce the frequency and consequences of uncontrolled, unplanned or accidental releases of hazardous substances into the environment. The objectives are obtained through proper environmental emergency planning so that companies are able to prevent, prepare for, respond to and recover from an environmental emergency. The regulations require facilities (among other things) to submit information to ECCC showing that an environmental emergency plan has been developed and tested. Regulatees must provide ECCC with the information in Schedules 4 and 5 of the regulations.

Facilities who do not submit this information are out of compliance with the E2 regulations. Without it, ECCC does not have confirmation that these facilities have created an emergency plan or tested it. These facilities are at a higher risk of not being able to respond to an E2 substance release at their facilities, posing an increased risk to the environment and human health. As such, ECCC conducted 377 inspections relating to Schedules 4 and 5, resulting in 488 enforcement actions.

Chromium Anodizing and Reverse Etching Regulations

In 2016-17, enforcement activities were conducted under the Chromium Electroplating, Chromium Anodizing and Reverse Etching Regulations (Chrome Regulations). The purpose of the Chrome Regulations is to protect the environment and the health of Canadians by reducing air emissions of hexavalent chromium compounds from facilities using chromic acid in their chromium electroplating, chromium anodizing or reverse etching operations.

Approximately 165 facilities in Canada are subject to the requirements of the Regulations. Regulatees in Canada use two methods provided for in the regulations for controlling the release of chromium compounds into the atmosphere: (i) use of a point source, and (ii) limiting the surface tension.

Approximately 80 facilities use the point source method. This requires the user to conduct a release test every five years; tests are carried out by consultants specializing in atmospheric emissions tests. The year 2016-17 was a pivotal year, with 42 tests being due on different dates depending on the regulated entity. ECCC enforcement officers observed several of the on-site tests, and all reports submitted by the consultants have or will be verified by ECCC staff with the necessary expertise.

For the 85 facilities using the surface tension method, they are required to measure and record the surface tension of the solution once a day when a tank is used. This data is sent to ECCC every six months. All reports have been verified by ECCC.

When alleged non-compliance was found, ECCC's enforcement officers took measures (or are taking measures) in accordance with the Compliance and Enforcement Policy for the Canadian Environmental Protection Act, 1999. In 2016-17, 94 inspections and two investigations were conducted, and 84 enforcement actions were taken.

Other highlights included enforcement activities under the following regulations: 468 inspections under the Tetrachloroethylene (PERC) Regulations, 426 inspections under the Export and Import of Hazardous Waste and Hazardous Recyclable Material Regulations, and 80 inspections under the Ozone-depleting Substances Regulations, 1998.

In total, under the CMP regulations, ECCC completed 989 investigations and 1569 inspections, leading to 901 written warnings, 27 environmental protection compliance orders, and 8 convicted subjects. ^{Footnote [1]}

Cyclical Enforcement CMP related projects for consumer products and cosmetics were put in place to determine compliance levels for rattles, liquid filled teethers, children's polyurethane foam (PUF) products, and cosmetics. For the products tested, there was 100% compliance to the respective phthalate requirements and 95% compliance to the targeted cosmetics, PUF, and lead requirements. In total, four (4) actions were taken: two recalls (for a non-compliant cosmetic, and non-compliant PUF product) and two stop distributions (for a children's product and cosmetic).

AR 2.1 Actual Results:

Public Health Agency of Canada

During 2016-17, the Public Health Agency of Canada (the Agency's) Environmental Health Officers (EHOs) continued to work with passenger conveyance industry stakeholders, including airlines, railways, cruise ships, ferries, buses and ancillary services such as flight kitchens and terminals, in order to identify and address potential risks to travellers. Activities were targeted using a public health risk assessment tool, and the Agency completed 392 public health inspections, eight outbreak investigations, 58 outreach and awareness activities, and took 1,400 water samples. When public health risks were identified, EHOs worked with operators to mitigate them. For example, conveyance and facility operators successfully resolved 96% of critical public health violations that were identified - above the target of 90%.

In addition, the Agency's Potable Water on Board Train, Vessels, Aircraft and Buses Regulations came into effect on September 2016, replacing the existing Potable Water Regulations for Common Carriers. The modernized Regulations require operators of passenger conveyances to meet water quality requirements and take measures to prevent contamination of water supplies, maintain on board potable water systems, conduct routine water sampling, maintain accessible records, and complete corrective measures should contamination be suspected or confirmed. The Agency continues to administer and enforce food safety provisions of the Food and Drugs Act on board passenger conveyances and at ancillary services, on behalf of the Canadian Food Inspection Agency. The new Regulations and authorities strengthen the Agency's ability to identify and address public health risks, and will help ensure the continued health protection of the travelling public in Canada.

Comments on variances:

Health Canada:

The variance between actual and planned spending is mainly due to the reallocation of funds within the department, the result of management's efforts to stabilize and control salary requirements through personnel departures and delays in staffing vacant positions, and the delay of consultation on the proposed regulatory framework for environmental assessment of active pharmaceutical ingredients in drugs.

Public Health Agency of Canada:

The variance between actual and planned spending is mainly due to increased compliance activities related to the implementation of new Potable Water Regulations and new Food and Drug Act authorities.

Environment and Climate Change Canada:

The variance between actual and planned spending is mainly due to internal reallocation to other priorities.

Results achieved by non-federal partners (if applicable)

Not Applicable

Federal Tobacco Control Strategy

General Information

Lead departments

Health Canada

Federal partner organizations

Health Canada

• Healthy Environments and Consumer Safety Branch, Tobacco Control Directorate
• First Nations and Inuit Health Branch
• Communications and Public Affairs Branch
• Regulatory Operations and Regions Branch

Public Health Agency of Canada

• Public Health Infrastructure
• Health Promotion and Disease Prevention

Public Safety Canada

• Akwesasne
• Policy Development

Royal Canadian Mounted Police

• Criminal Intelligence
• Technical Investigations

Canada Border Services Agency

• Risk Assessment
• Admissibility Determination

Canada Revenue Agency

• Taxpayer and Business Assistance
• Assessment of Returns and Payment Processing

Public Prosecutions Service Canada

• Not applicable

Non-federal and non-governmental partner

Not applicable

Start date of the horizontal initiative

April 2012^{Footnote a}

End date of the horizontal initiative

March 31, 2017^{Footnote a}

Total federal funding allocated (start to end date) (dollars)

$225,268,023

Total federal planned spending to date (dollars)

$44,959,170

Funding contributed by non-federal and non-governmental partners (dollars)

Not applicable

Governance structures

Health Canada is the lead department for the federal government with responsibility for the coordination and implementation of the FTCS.

Federal partners manage the control of tobacco products through monitoring and assessing the illicit and licit tobacco markets:

• Public Safety Canada - leads and works with federal partners to develop and coordinate strategic approaches and activities to monitor and combat contraband tobacco activity and related crime;
• The Royal Canadian Mounted Police - works with federal partners to identify and investigate criminal activities and to coordinate information on national and international contraband tobacco issues;
• The Canada Border Services Agency - increases knowledge of contraband domestically and internationally by liaising with tobacco authorities at all levels and by monitoring and providing regular reports on both national and global contraband tobacco. The Canada Border Services Agency provides reports, information and guidance to the Department of Finance Canada on matters that will impact the future tax structure of tobacco;
• The Canada Revenue Agency - administers the Excise Act 2001, which governs federal taxation of tobacco products and regulates activities involving the manufacture, possession and sale of tobacco products in Canada; and,
• Public Prosecutions Service Canada - monitors federal fines imposed in relation to tobacco and other types of offences in order to enforce and recover outstanding fines.

Contact information

James Van Loon
Director General
Tobacco Control Directorate
Healthy Environments and Consumer Safety Branch
Health Canada
1^st Floor, Main Stats Building
150 Tunney's Pasture Driveway, Tunney's Pasture
Ottawa, ON, K1A 0K9
Telephone number: 613-941-3202
E-mail address: james.vanloon@canada.ca

Results Information

Description of the horizontal initiative

The FTCS was initiated in 2001. The policy authority for the current FTCS expires March 31, 2018. In 2012, the Strategy was renewed for five years to provide a focused federal presence to preserve the gains of the past decade and continue the downward trend in smoking prevalence. The renewed Strategy focuses on the core areas of federal responsibility and invests in new priorities including populations with higher smoking rates. The objective of the Strategy is to reduce the use of tobacco and the potential for tobacco-related death and disease in Canada.

Fiscal year of planned completion of next evaluation

Not applicable

Shared outcomes of Federal Partners

To preserve the gains made over the past decade and to continue the downward trend in smoking prevalence.

Performance indicators

PI 1.1 - Performance Indicators: Health Portfolio

• % of current Canadian (aged 15+) smokers reduced;
• % of products that are deemed to be non-compliant with the Tobacco Act and its regulations related to manufacturing and importing;
• # of World Health Organization Framework Convention on Tobacco Control (WHO FCTC) reports issued on progress every two years; and,
• #, nature and reach (# of participants) in interventions/projects implemented by Public Health Agency of Canada and First Nations and Inuit Health Branch.

PI 2.1 - Performance Indicators: Public Safety Canada

• 100% of FTCS activities that are coordinated with its partners, with provinces/territories (P/Ts) and other stakeholders;
• 100% of FTCS activities/outputs that generate knowledge/awareness of the contraband tobacco market;
• More than 10 of environmental scans, policy analyses, threat assessments, intelligence, and other reports as well as surveys and studies generated and used to: inform senior officials; develop policies and/or directions; and support participation to the World Health Organization; and,
• 1 of 2 Interdepartmental Strategic Level Forum meetings held.

PI 3.1 - Performance Indicators: Royal Canadian Mounted Police

• Number of intelligence reports disseminated to partners such as: Canada Revenue Agency, Public Safety, Financial Transactions and Reports Analysis Centre of Canada and CBSA; and,
• Number of engagements and forums with FTCS partners, particularly within the Public Safety Portfolio (committees, working groups, etc.).

PI 4.1 - Performance Indicators: Canada Border Services Agency

• # of reports related to contraband tobacco; and,
• # of engagement forums with provincial and territorial governments and other authorities.

PI 5.1 - Performance Indicators: Canada Revenue Agency

• % of audits and regulatory reviews completed; and,
• % of returns and rebates processed and the gross excise duty assessed.

Targets

T 1.1 - Targets: Health Portfolio

• Fewer than 15% of Canadians (aged 15+) report they smoke; and,
• Less than 5% of tobacco products are non-compliant with the Tobacco Act and its regulations.

T 2.1 - Targets: Public Safety Canada

• 100% of FTCS activities are coordinated with its partners, with P/Ts and other stakeholders;
• 100% of FTCS activities/outputs generate knowledge/awareness of the contraband tobacco market;
• 10 environmental scans, policy analyses, threat assessments, intelligence, and other reports as well as surveys and studies generated and used to: inform senior officials; develop policies and directions, and support participation to the World Health Organization; and,
• Two Interdepartmental Strategic Level Forum meetings held.

T.3.1 - Targets: Royal Canadian Mounted Police

• Two intelligence reports disseminated to partners: the FTCS Annual Report and the FTCS Mid-Year Report.
• The RCMP will continue to be actively involved in the following three forums:

1. The Interprovincial Investigations Conference: The aim is to develop, increase and maintain cooperation among all those who are involved in combating the contraband tobacco market by providing current information and contacts in other jurisdictions.
2. The U.S./Canada Tobacco Diversion Workshop: The workshop aims to bring together managers, investigators and analysts as well as relevant agencies involved in tobacco enforcement. The workshop is part of an ongoing commitment by the core agencies to address the growing illicit tobacco market and its cross-border flow through an integrated policing and intelligence-sharing approach.
3. The Joint Agency Group Contraband Tobacco Control Meeting: The aim is to develop, increase and maintain cooperation among all those who are involved in combating the contraband tobacco market by providing current information and contacts in other jurisdictions.

T 4.1 - Targets: Canada Border Services Agency

• 2016-17 targets are under development. However, key highlights will be reported on in the 2016-17 Departmental Results Report.

T 5.1 - Targets: Canada Revenue Agency

• 100% of audit and regulatory review coverage of federal tobacco licensees, and,
• 100% of accounts maintained and transactions processed.

Data source and frequency of monitoring and reporting

Not applicable

Expected outcome or result of non-federal and non-governmental partners

Not applicable

ER 1.1 - Expected Results: Health Portfolio

The Health Portfolio will achieve results in the following areas:

• Regulations and Compliance - Lead the development of regulations, including the development of an approach for the plain packaging of tobacco products. Conduct compliance monitoring activities and undertake enforcement measures with respect to the Tobacco Act and its regulations;
• Research - Conduct scientific and market research and surveillance to support decision making and the development of policies and regulations;
• Policy - Lead the process for renewal of the policy authority of the FTCS, work towards the development of an approach for the plain packaging of tobacco products and facilitate stakeholder engagement. As well, lead Canada's participation in the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) obligations, as well as collaborating with provinces and territories in tobacco control activities;
• Litigation - Provide base funding for tobacco litigation and for the defense of the Tobacco Act and its regulations; and,
• Community interventions - Leverage existing networks and seek innovative partnerships that contribute to an integrated approach to chronic disease prevention. Work with partners from the public and private sectors to promote healthy living and prevent chronic diseases caused by risk factors such as tobacco use. Supporting interventions and programming that aim to reduce tobacco use, particularly among young adults, First Nations on-reserve and Inuit in recognized Inuit communities.

ER 2.1 - Expected Results: Public Safety Canada

• Provide contribution funding to build on the capacity of the Akwesasne Mohawk Police Service to address contraband tobacco issues within the community;
• Provide leadership and strategy development, in consultation with federal partners, on international initiatives to combatting illicit trade in tobacco, including the development of Canada's position vis-à-vis the Protocol to Eliminate the Illicit Trade in Tobacco Products under the World Health Organization Framework Convention on Tobacco Control; and,
• Contribute to the development of domestic evidence-based policies and initiatives to support law enforcement efforts to fight organized crime involved in the contraband tobacco market, including co-chairing the inter-departmental Strategic Level Forum meetings.

ER 3.1 - Expected Results: Royal Canadian Mounted Police

• Criminal Intelligence: The Royal Canadian Mounted Police (RCMP) will collect, collate, and analyze data related to the contraband tobacco market and provide regular reports to partner law enforcement agencies, government and non-governmental agencies. The RCMP will continue to participate in joint agency meetings and be involved in information and intelligence sharing with domestic and international law enforcement partners. In addition, the RCMP will provide support and subject matter expertise to criminal investigations and prosecutions, including developing and delivering training and outreach initiatives on new and existing legislation related to contraband tobacco.
• Technical Investigations: The RCMP will provide technical tools and employ technology to enhance detection and monitoring of illegal border intrusions. Advancements in technology are essential to border security and to providing vital intelligence for criminal investigations and border security. Border surveillance technology is deployed to detect cross-border criminality, not merely the smuggling of contraband tobacco. Front-line police officers rely heavily on this technology in the fight against well-orchestrated organized crime networks that target the border to move illicit tobacco products.

ER 4.1 - Expected Results: Canada Border Services Agency

Risk Assessment

• Provide advice to the Department of Finance Canada on matters that will impact the future tax structure of tobacco;
• Monitor and report on the contraband tobacco situation in Canada;
• Expand cooperation with international and national law enforcement partners; and,
• Collection of tobacco duties imposed on personal importations of returning Canadians.

ER 5.1 - Expected Results: Canada Revenue Agency

• Ensure compliance with legislative requirements imposed on the manufacture, possession and sale of tobacco products in Canada;
• Verify export activity;
• Work with stakeholders to monitor and assess the effectiveness of measures used to reduce contraband tobacco;
• Support RCMP and CBSA enforcement activities; and,
• Maintain accounts and provide services related to transactions (including refunds), and produce reports on tobacco-related activities.

AR 1.1 - Actual Results Achieved: Health Portfolio

Marketing research activities/results included:

• 33 experiential engagement events from February to March 2017.
• Over 55,000 young adults (aged 20-24) were engaged on the topic of tobacco cessation.
• Average length of engagement was 3 min 33 sec.
• 895 post-event surveys were completed (out of 2,670 requested).
  • 71% of survey respondents reported that information received at an event motivated them to consider quitting smoking.
• Over 33,000 web visits to Breakitoff.ca and jetelaisse.ca.
• Facebook and Instagram promoted posts achieved over 8.5 million impressions and over 59,000 clicks.
• Google AdWords achieved over 995,000 impressions and over 15,000 clicks.
• YouTube pre-roll videos achieved over 4.6 million impressions and over 349,000 views.

Policy activities/results included:

• The Health Portfolio strengthened its tobacco control efforts and advanced policy positions consistent with Canada's global and domestic tobacco control agenda through membership in the WHO FCTC. As Party to the Convention, Canada's contribution to the WHO FCTC helped advance the implementation of an international program of work.
  • Canada actively participates in the implementation of the Convention by attending the sessions of the Conference of the Parties (COP), which is the governing body that sets the direction for the implementation of the Convention and determines the work of the Convention Secretariat. On November 7-12, 2016, Canada attended the seventh session of the COP (COP7) in New Delhi, India and was effective in advancing governance and institutional issues related to: sustainable measures to support the implementation of the Convention; key principles for a hosting arrangement with the WHO; workplan and budget for the 2018-2019 biennium; performance reports for the 2014-2015 workplan; international cooperation; financial resources and mechanisms of assistance; fundraising efforts; evaluation of the Head of the Convention Secretariat; and, amendments to the rules of procedure.
  • Canada also supported the implementation of the Convention by participating in bilateral meetings with like-minded countries to exchange information on lessons learned and current challenges, including working with tobacco control partners in the Americas region and with the informal network of countries that meet annually to discuss challenges on the implementation of the Convention. In addition, Canada was very active in negotiations of the Uruguay Declaration and the 2016 World Health Assembly resolution (May 2016) that aims at improving synergies with the Conference of the Parties to the FCTC.
  • Several reports have been produced by the FCTC Convention Secretariat in 2016 to document the progress achieved in the implementation of the Convention. Key reports included the Global progress in implementation of the WHO FCTC; and the Impact Assessment of the WHO FCTC.
  • Additional reports to document the progress in the implementation of individual articles of the WHO FCTC were also produced by the Convention Secretariat and can be accessed on the COP7 website.

Community Interventions activities/results included:

• PHAC continues to successfully monitor and implement community interventions using an innovative partnerships model with public and private sectors that takes an integrated approach to promoting healthy living and preventing chronic diseases by addressing risk factors such as tobacco use.
  • MANTRA (http://www.mantrainc.ca/) is leading a project which aims to increase the number of healthcare professionals being trained to provide smoking cessation counselling through the University of Manitoba. MANTRA expanded Cancer Care Manitoba's Quit Smoking program from one to seven outreach centres across the province and reached a total of 102 health professionals through tobacco cessation training.
  • Run to Quit (http://www.runtoquit.com/), a large-scale national cessation project with the Canadian Cancer Society and the Running Room, helps smokers quit by incorporating running into their daily lives. It was offered online and in 21 stores in six provinces to a total of 1,079 participants. Results for the 2016-17 fiscal year indicated that 97% of participants who completed the program reported it increased their physical activity. Six months after Run to Quit completed its first year, 28% of participants reported they had quit smoking during the 10-week training program and had successfully not smoked since, while 43% of participants interviewed said they were still running, on average, three times a week.
  • The Picking up the Pace project with the Centre for Addiction and Mental Health was introduced in January 2017 with the aim of enhancing the content of online training program on tobacco cessation. In addition, an implementation tool and peer coaching model was developed for primary care providers and healthcare practitioners to build capacity to concurrently address other risk factors for chronic disease prevention in conjunction with smoking cessation.
• As of 2016-17, a select number of First Nations and Inuit communities, supported through 16 projects and 3 strategies under the First Nations and Inuit component of the FTCS, have completed year three of implementation measures to establish comprehensive tobacco-control strategies and interventions aimed at reducing and preventing tobacco misuse, including reducing smoking rates. Early reported successes include:
  • An increase in indoor and outdoor smoke-free spaces (from 676 in 2014-15 to 1688 in 2015-16).
  • An increase in smoking-related resolutions passed by governance bodies (from 23 in 2014-15 to 53 in 2015-16).
  • Initiation of 3197 community members in a smoking-cessation program/ intervention in 2015-16 (35.7% completed program/ intervention, 5.1% reduced levels of commercial tobacco use, and 1.6% quit).

Litigation, regulations and compliance activities/results included:

• Based on the manufacturer inspections conducted throughout 2016-17, Health Canada reports that the manufacturing sector was 99% compliant regarding the presence of prohibited additives, and 86% compliant with the promotion of prohibited additives. In addition, compliance with tobacco product labelling requirements during this timeframe was 94%.

AR 2.1 - Actual Results Achieved: Public Safety Canada

• Through the FTCS, PS provided $450,000 to the Akwesasne Mohawk Police Service to address contraband tobacco issues within the community by supporting surveillance and monitoring of illicit trade in tobacco and allows for participation in join force operations that have led to charges and seizures of contraband tobacco.
• Continued to lead domestic and international contraband tobacco-related policy initiatives, such as the development of an interdepartmental position vis-à-vis the World Health Organization Protocol to Eliminate Illicit Trade in Tobacco Products.
• In September 2016, Public Safety co-chaired with CRA the Director General-level Strategic Level Forum and its supporting working group meetings, which provide opportunities for partners to discuss potential policy and legislative measures, share best practices and identify gaps/opportunities on contraband tobacco issues. The second Strategic Level Forum meeting was postponed to 2017-18, due to changes in file responsibility within PS.

AR 3.1 - Actual Results Achieved: Royal Canadian Mounted Police

• Criminal Intelligence: During the reporting period (2016-17), the RCMP participated in the Interprovincial Investigators Council on Contraband Tobacco and gave a national-level presentation at the annual conference. The RCMP also participated in the US/Canada Contraband Tobacco Diversion workshop and the Joint Agency Group on Contraband Tobacco. The RCMP continued to respond to numerous consultative requests from FTCS partners with respect to contraband tobacco issues. The RCMP also responded to a consultative request from Parliamentarians in regards to contraband tobacco issues, particularly any anticipated effects of proposed plain packaging of tobacco products legislation. During 2016-17, the tobacco analyst position at the RCMP was vacant that resulted in delayed the production of the 2016 FTCS reports.
• Technical Investigations (FTCS Funded) - During the reporting period (2016-17), funding was allocated to support the deployment and maintenance of border surveillance technologies to assist front-line police officers to detect and disrupt cross-border criminality, including the smuggling of contraband tobacco. Specifically, funding was allocated to the following Divisions: E (British-Columbia), D (Manitoba), J (New-Brunswick), and O (Ontario). Across the funded divisions, a total of 94 border sensors / cameras were deployed. Ever-greening of equipment for border surveillance remains a challenge under the current financial envelope. Since the divisions are operating with limited funds, Federal Policing Operations provides additional funding on an urgent basis to ever-green some of the older sensors deployed.

AR 4.1 - Actual Results Achieved: Canada Border Services Agency

• Provided status updates on the contraband tobacco market, as well as seizure statistics, at the Department of Finance chaired Tobacco Enforcement meetings;
• Provided an ongoing assessment of Canada's contraband tobacco market detailing characteristics and trends encountered by the CBSA;
• Collaborated with other agencies, such as the RCMP and the Akwesasne Mohawk Police, which resulted in an increase in referrals for examination for both commercial and travelers. Identified indicators and modus operandi not previously known; identified emerging trends and threats and shared this information with CBSA regional offices, and with domestic and international partners, including the World Customs Organization;
• Continued to collect duties and taxes at ports of entry on all personal importations of tobacco;
• During 2016-17, the CBSA made 1,403 tobacco seizures; and
• Although this data is not collected by the CBSA, the CBSA does engage with the provincial, territorial and other authorities on this initiative.

AR 5.1 - Actual Results Achieved: Canada Revenue Agency

Taxpayer and business assistance:

• Audits and regulatory reviews were performed to ensure compliance with legislative requirements imposed on the manufacture, possession and sale of tobacco products in Canada. Target of 100% audit and regulatory review coverage of federal tobacco licensees was achieved.
• Information about specific tobacco transactions as well as expert testimony and affidavits, as required, were provided to support RCMP/CBSA enforcement activity.
• Officials participated in a number of committees dealing with monitoring and control of tobacco products, including those dealing with interprovincial issues.

Assessment of returns and payment processing:

• Processed returns and refunds to ensure correctness and maintained systems and reporting capabilities to meet program requirements. Target of 100% of accounts maintained and transactions processed was achieved.

Performance Summary

Federal organizations	Link to department's Program Alignment Architecture	Contributing programs and activities	Link to depart-ment's Strategic Outcomes	Link to government priorities	Total allocation (from start to end date) (dollars)	2016-17 Planned spending (dollars)	2016-17 Actual spending (dollars)	2016-17 Expected results	2016-17 Performance indicators	2016-17 Targets	2016-17 Actual results
Health Canada	2.5.1 Tobacco control	Policy and International Commitments; Research & Surveillance; Regulations & Compliance.			$158,759,657	$29,648,999	$29,128,423	ER 1.1	PI 1.1	T 1.1	AR 1.1
	3.1.1.3 Healthy Living	Community Interventions.			$22,140,042	$6,500,000	$6,182,509
Public Health Agency of CanadaTable 2 Footnote *	1.1.2 Public Health Information and Networks	Policy & International Commitments			$1,025,000	$205,000	$227,773
	1.2.3 Chronic (non-communicable Disease and Injury Prevention	Community Interventions			$9,859,958	$2,250,000	$1,655,949
Public Safety Canada	Law Enforcement Leadership	Akwesasne			$2,250,000	$450,000	$450,000	ER 2.1	PI 2.1	T 2.1	AR 2.1
		Policy Development			$800,000	$160,000	$109,852
Royal Canadian Mounted PoliceTable 2 Footnote **	1.1.2.3 Criminal IntelligenceTable 2 Footnote **	Criminal Intelligence			$4,246,981	$762,177	$762,177	ER 3.1	PI 3.1	T 3.1	AR 3.1
	1.1.3.1 Technical Investigations	Technical Investigations			$4,039,664	$797,851	$797,851
	Internal Services				$502,221	$259,435	$259,435
Canada Border ServicesTable 2 Footnote ***	1.1 Risk Assessment	Policy and Intervention; Regulations and Compliance			$15,200,000	$3,019,208	$3,019,208	ER 4.1	PI 4.1	T 4.1	AR 4.1
Canada Revenue Agency	PA1. Taxpayer and business assistance PA2. Assessment of returns and payment processing	Regulations & Compliance			$4,444,500	$906,500	$888,910	ER 5 .1	PI 5.1	T 5.1	AR 5.1
Public Prosecutions Service Canada	Office of the Director of Public Prosecutions	Regulations & Compliance			$2,000,000	$0	$0	N/A	N/A	N/A	N/A
Total for all federal organizations					$225,268,023	$44,959,170	$43,482,087	N/A	N/A	N/A	N/A
Table 2 Footnotes Table 2 Footnote 1 Public Health Agency of Canada funding includes a re-profile of $1.2M from 2012-13 over the subsequent four years. Return to Table 2 footnote * referrer Table 2 Footnote 2 RCMP planned spending figures have been adjusted to reflect approved annual reference levels within the Federal Policing Program. Under the RCMP's newly established Federal Policing Service Delivery Model, resources are continuously re-aligned to address the highest level operational priorities. As a result, actual expenditures for the Federal Tobacco Control Strategy can be expected to fluctuate from year to year based on emerging and shifting operational priorities. Return to Table 2 footnote ** referrer Table 2 Footnote 3 Federal Tobacco Control Strategy (FTCS) budget reduced due to reductions in the Canada Border Services Agency's overall A-base authorities in 2013-2014. Return to Table 3 footnote *** referrer

Comments on Variance

HC Tobacco Control program - The variance of actual and planned spending is mainly due to lower than anticipated provincial and territorial funding requirements for the pan-Canadian Quitline and delays in large contracts.

HC Healthy Living program - Expenditures were less than anticipated due to the coordination of FTCS project activities with existing ongoing community based program funding, resulting in some financial efficiency.

FNIHB:

Expenditures were less than anticipated due to the coordination of FTCS project activities with existing ongoing community based program funding, resulting in some financial efficiency.

PHAC :

The variance between the planned and actual spending for the Public Health Agency of Canada is related to a) Canada's voluntary assessed contribution to the WHO FCTC being calculated and paid in USD, resulting in a $22,773 difference due to currency fluctuation in 2016-17; and b) Given the complex nature of the projects and partnerships funded under the Agency's Multi-sectoral Partnership approach, not all funds were expended in 2016-17 due to the required timelines to negotiate projects with matched funds and pay for performance milestones.

Public Safety:

The variance between planned and actual expenditures for policy development (salary for one FTE, EMB and accommodations) at Public Safety Canada is due to the departure of the main analyst for this initiative as well as the transfer of responsibility to another division within the department.

Jordan's Principle - A Child-First Initiative

General Information

Lead departments

Health Canada

Federal partner organizations

Indigenous and Northern Affairs Canada

Non-federal and non-governmental partner

Not applicable

Start date of the horizontal initiative

September 29, 2016

End date of the horizontal initiative

March 31, 2019

Total federal funding allocated (start to end date) (dollars)

$382,500,000

Total federal planned spending to date (dollars)

HC: $88,543,140

INAC: $256,860

Total: $88,800,000

Funding contributed by non-federal and non-governmental partners (dollars)

Not applicable

Governance structures

The Jordan's Principle - A Child-First Initiative is overseen by two levels of governance: a Director General-level Steering Committee and the Jordan's Principle Oversight Committee (JPOC). The JPOC includes Assistant Deputy Ministers (ADM) from INAC and HC, as well as external partners, including the Assembly of First Nations and the First Nations Child and Family Caring Society, which meets to:

• provide oversight and strategic direction on the implementation of this initiative;
• oversee financial management of investments (Enhanced Service Coordination and Service Access Resolution fund);
• discuss requests, policy and programming issues and seek resolution and solutions (respectively); and,
• monitor progress and results.

Contact information

Bonnie Beach
Jordan's Principle Director
Health Canada
613-960-4480
bonnie.beach@canada.ca

Results Information

Description of the horizontal initiative

Jordan's Principle applies to all First Nations children and all jurisdictional disputes, including those between federal government departments. The Child-First Initiative is one of a series of proactive measures under Jordan's Principle to address the needs of the most vulnerable children.

The Jordan's Principle - A Child-First Initiative administers contribution agreements and direct departmental spending to help ensure that First Nations children have access to government health, social, and educational supports and services, in order to obtain substantial equity.

The Government of Canada has committed up to $382.5 million in new funding for this proactive response implemented over three years starting in 2016-17, with the objective to improve service coordination and ensure service access resolution so that children's needs are assessed and responded to quickly. This program uses funding from the following transfer payment: First Nations and Inuit Primary Health Care. This initiative is a response to the Canadian Human Rights Tribunal (CHRT) order.

This initiative aligns with the Health Canada Strategic Outcome 3: First Nations and Inuit communities and individuals receive health services and benefits that are responsive to their needs so as to improve their health status, and with Indigenous and Northern Affair's Strategic Outcome 2: The People - Individual, family and community well-being for First Nations and Inuit.

Fiscal year of planned completion of next evaluation

An initiative review (i.e., Formative Evaluation) is scheduled to be completed by 2018-19.

Shared outcomes of Federal Partners (HC & INAC)

First Nations children receive health, education and social supports.

Performance indicators (HC & INAC)

• The number of service requests supported through the Jordan's Principle -A Child-First Initiative.
• The number and percentage of First Nations parents and guardians requesting services for their children through the Jordan's Principle - A Child-First Initiative reporting on follow-up that they have access to a coordinated system of supports and services.
• The number of First Nations children requesting services through the Jordan's Principle - A Child-First Initiative who have accessed specific services by type of service (such as respite care, home and community care, speech therapy, occupational therapy, physical therapy).

Targets (HC & INAC)

Implement the program in accordance with the (CHRT) order.

Data source and frequency of monitoring and reporting (HC & INAC)

• Application intake forms (upon each request)
• Focal Point tracking sheets (weekly)
• Contribution Agreement Data Collection Instruments (annual reporting)
• Reporting from partner organizations (survey)

Expected outcome or result of non-federal and non-governmental partners

Not applicable

Performance Summary

Federal organizations	Link to department's Program Alignment Architecture	Contribut-ing programs and activities	Link to department's Strategic Outcomes	Link to governm-ent priorities	Total allocation (from start to end date) (dollars)*	2016-17 Planned spending (dollars)*	2016-17 Actual spending (dollars)*	2016-17 Expected results	2016-17 Performance indicators	2016-17 Targets	2016-17 Actual results
Health Canada	First Nations and Inuit Primary Health Care	3.1.3.3 Jordan's Principle - A Child-First Initiative.	Strategic Outcome 3: First Nations and Inuit communities and individuals received health services and benefits that are responsible to their needs so as to improve their health status.	Diversity is Canada's Strength	$381,215,704 Table 3 Footnote **	$88,543,140	$15,979,524	First Nations children access health, social and educational supports and services they need.	See below	See below	See target (T 1.1)
Indigenous and Northern Affairs Canada	Assisted Living; First Nation Child and Family Services; Income Assistance; Education programs	2.2.5 Family Violence Prevention	Strategic Outcome 2: The People - Individual, family and community well-being for First Nations and Inuit.	Diversity is Canada's Strength	$1,284,296	$256,860	$319,878	First Nations children access health, social and educational supports and services they need.	See below	See below	See target (T 1.1)
Total for all federal organizations					$382,500,000	88,800,000	$16,299,402	Not applicable
Table 3 Footnotes Table 3 Footnote 1 The amounts include Shared Services Canada core information technology services and PWGSC accommodation costs. Return to Table 3 footnote * referrer Table 3 Footnote 2 Total allocation includes a reserve fund, which is administered by HC to ensure that HC and INAC can cover the services and supports required to address the needs of First Nations children. Return to Table 3 footnote ** referrer

Performance indicators

Health Canada & Indigenous and Northern Affairs Canada

PI 1.1

• The number of service requests supported through the Jordan's Principle - A Child-First Initiative.
• The number and percentage of First Nations parents and guardians requesting services for their children through the Jordan's Principle - A Child-First Initiative reporting on follow-up that they have access to a coordinated system of supports and services.
• The number of First Nations children requesting services through the Jordan's Principle - A Child-First Initiative who have accessed specific services by type of service (such as respite care, home and community care, speech therapy, occupational therapy, physical therapy).

Targets

Health Canada & Indigenous and Northern Affairs Canada

T 1.1

A target will be set once a baseline is established after the first year results are gathered and analyzed.

According to Health Canada, in the first nine months of implementing the Jordan's Principle- Child First Initiative, from July 5, 2016 to March 31, 2017, an estimated 4,940 requests for products and services were approved to support First Nations children. In the first three months of fiscal year 2017-2018, from April 1, 2017 to June 30, 2017, an estimated 10,947 requests for products and services have been approved. This initiative is demand driven, as such the Jordan's Principle- Child First Initiative team is working to assess requirements and ensure First Nations children have access to the health, social and educational supports and services they need.

Health Canada has developed a survey template that will be used to assess the level of satisfaction of parents and/or guardians whose children have received service through Jordan's Principle-CFI. This will include children funded under INAC authorities. The survey will be administered for FY 2017-18.

Comments on variance

HC:

Health Canada was not able to expend all of its 2016-17 budget allocation due to delays in negotiating contribution agreements with partner organizations to implement the Service Coordination function. The unspent funding was reprofiled to 2017-18 and 2018-19 to address the growing number of requests for services/supports following the CHRT's rulings and orders expanding the definition and scope of Jordan's Principle, as well as an increased awareness and uptake of the Child-First Initiative since the implementation of the Service Coordination mechanism.

INAC:

No planned spending was reported in the 2016-17 Report on Plans and Priorities. The Jordan's Principle - A Child-First Initiative is a demand-driven initiative; the variance between resources received and actual spending is mainly due to in-year funding received to support the initiative.

• Previous Page
• Table of Contents
• Next Page